How much did Lone Star pay for Hillenbrand?
McKesson Corporation acquired U.S. Oncology in a strategic transaction valued at approximately 2.16 billion US dollars. The multi-billion-dollar cash and debt deal combined McKesson's massive pharmaceutical distribution capabilities with U.S. Oncology's extensive network of community-based cancer care centers and group purchasing organizations. McKesson financed the acquisition using a combination of approximately 400 million dollars in cash on hand and 1.7 billion dollars in new borrowings, significantly expanding its vertical integration within specialized oncology care, physician practice management, and advanced clinical distribution channels nationwide.
Related FAQs
Hillenbrand, Inc. commands a total corporate market capitalization of approximately $2.26 billion USD.
Weight loss programs utilizing GLP-1 treatments through Hims & Hers typically range from $149 to $299 per month for specific medication options, alongside a required Hims Weight Loss Membership subscription fee which starts at $39 for the first mo...
Hillenbrand Inc. is a fully authentic, publicly traded industrial enterprise listed on the New York Stock Exchange under the ticker symbol HI.
Hillenbrand is a quintessential American industrial corporation with its global headquarters firmly established in Batesville, Indiana.